Showing results (351-360 of 446) with videos related to

Sort By:
Pageof 45
Neuroimage. Clinical|January 5, 2021
Comparing cortical signatures of atrophy between late-onset and autosomal dominant Alzheimer diseaseAylin Dincer, Brian A Gordon, Amrita Hari-Raj, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 26, 2024
α-Synuclein seed amplification assay detects Lewy body co-pathology in autosomal dominant Alzheimer's disease late in the disease course and dependent on Lewy pathology burdenJohannes Levin, Simone Baiardi, Corinne Quadalti, et al.
Brain : a Journal of Neurology|February 21, 2018
Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer's diseaseNicolai Franzmeier, Emrah Düzel, Frank Jessen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 22, 2021
Modeling autosomal dominant Alzheimer's disease with machine learningPatrick H Luckett, Austin McCullough, Brian A Gordon, et al.
Neurogenetics|January 22, 2013
Mutations in SLC20A2 are a major cause of familial idiopathic basal ganglia calcificationSandy Chan Hsu, Renee L Sears, Roberta R Lemos, et al.
Brain : a Journal of Neurology|May 17, 2022
Autosomal dominant and sporadic late onset Alzheimer's disease share a common in vivo pathophysiologyJohn C Morris, Michael Weiner, Chengjie Xiong, et al.
JAMA Neurology|October 16, 2023
Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer DiseaseZahra Shirzadi, Stephanie A Schultz, Wai-Ying W Yau, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 7, 2013
Regional variability of imaging biomarkers in autosomal dominant Alzheimer's diseaseTammie L S Benzinger, Tyler Blazey, Clifford R Jack, et al.
Brain : a Journal of Neurology|February 4, 2025
The landscape of autosomal-dominant Alzheimer's disease: global distribution and age of onsetHaiyan Liu, Thomas W Marsh, Xinyu Shi, et al.
Acta Neuropathologica|June 3, 2025
Immunohistochemical evaluation of a trial of gantenerumab or solanezumab in dominantly inherited Alzheimer diseaseCharles D Chen, Erin E Franklin, Yan Li, et al.
Pageof 45